Meet Acumetis at Asembia ASX26
Acumetis (formerly Herspiegel) will be attending Asembia AXS Summit 2026, widely recognized as the epicenter of the specialty pharmacy industry. With more than 8,000 attendees—many of whom are senior decision-makers—Asembia is where leaders across pharma, biotech, payer, and specialty pharmacy organizations come together to shape the future of patient access, distribution, and commercialization.
As the industry continues to evolve, organizations are facing increasing pressure to improve access, affordability, and patient experience while navigating complex reimbursement and channel dynamics. Asembia provides a unique opportunity to engage in practical, forward-looking conversations on these challenges.
Why Meet with Acumetis
Acumetis works with leading life sciences organizations to navigate complex access and commercialization challenges with clarity and confidence.
At Asembia, our team will be engaging in conversations focused on:
- Translating strategy into execution across patient access and specialty channels
- Identifying practical opportunities to improve patient access and outcomes
- Navigating evolving payer, policy, and distribution dynamics
- Applying real-world insights to drive better decision-making
Where to Find Us
Acumetis will be attending Asembia AXS Summit throughout the week at the Wynn & Encore.
Our team will be available for scheduled meetings and informal conversations across the conference. If you would like to connect, we recommend booking time in advance as schedules fill quickly during the event.
Key conference dates:
- April 26–30, 2026
- Wynn & Encore, Las Vegas
Key Topics We’re Discussing
- Direct-to-Patient (DTP) and Direct-to-Employer (DTE) strategies
- The evolving role of specialty pharmacy and HUB models
- AI’s growing impact on patient access and engagement
- Policy shifts including MFN and pricing reform
- Using real-world data to improve access and outcomes
Patient Access & Support Survey
Each year, our Patient Access and Support team surveys select patient services and trade leaders to understand how key trends and market forces are shaping patient services, trade, and the overall patient experience.
This year’s survey focuses on:
- The role of AI in patient access and engagement
- Expansion of direct-to-patient models
- Shifting dynamics between HUBs and specialty pharmacies
The survey takes approximately 10 minutes to complete, and all responses are fully blinded.
Participants will receive aggregated, anonymized results, which will be available by April 26 for offline review and will be shared in person at Asembia.
Who You’ll Meet From Acumetis
Brian Torres – Senior Leader, Patient Access Strategy.
Brian brings extensive experience in patient access and commercialization strategy.
Swathi Rangan – Leader, Patient Services & DTP Strategy
Swathi specializes in patient services transformation and direct-to-patient engagement.
Collin Wolf, PharmD – Director, Specialty Pharmacy Strategy
Collin combines clinical expertise with commercial insight.
Lynne Sager – Leader, Patient Support Programs
Lynne has deep experience designing patient support programs.
James Convery – Market Access Strategy Lead
James focuses on payer strategy and reimbursement environments.
Morgan Kagel – Commercial Strategy Consultant
Morgan supports commercialization and access transformation.
Sureka Gattu, PhD – Scientific Strategy Lead
Sureka supports evidence-based decision making.
Will Sargent – Commercial Strategy Leader
Will focuses on commercial performance and execution.
Karl Freemyer – Market Access & Policy Expert
Karl brings expertise in access and policy strategy.
Chris Grimes-Crompton – Strategy & Transformation Leader
Chris supports transformation across patient access models.